Clinical Trial Update: Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing safety and tolerability of Repatha (evolocumab) in Indian participants with Homozygous Familial Hypercholesterolemia; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Repatha (Evolocumab)

Snippet

Sponsor: Amgen | Conditions: Homozygous Familial Hypercholesterolemia HoFH | Phase 4 | Status: COMPLETED | Results posted: 2020-11-03